Literature DB >> 2544670

Persistent replication of herpes simplex virus type 1 in JOK-1 cells.

K Thiele1, S Mittnacht, H Kirchner.   

Abstract

Infection of the human B cell line JOK-1 with herpes simplex virus type 1 persisted over a period of more than 12 months (to date). Although limited cytopathic effects were seen, viral infection did not lead to extinction of the culture. Infectious centre assays, performed at various times after infection, revealed that only a small proportion of cells (1 to 10%) produced infectious virus particles. However, immunofluorescence studies showed that at any given time considerably more cells than calculated by infectious centre assays contained the immediate early viral protein ICP4 and expressed viral glycoproteins. These observations were confirmed by in situ hybridization analyses which revealed the presence of viral DNA even in cells not producing infectious particles. Since no evidence for the involvement of interferon could be found, some other so far unknown intrinsic property of the cells must be responsible for the restriction of virus replication and/or maturation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544670     DOI: 10.1099/0022-1317-70-7-1907

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  3 in total

1.  Characterization of a potent refractory state and persistence of herpes simplex virus 1 in cell culture.

Authors:  Cristina Barreca; Peter O'Hare
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Human corneal cells and other fibroblasts can stimulate the appearance of herpes simplex virus from quiescently infected PC12 cells.

Authors:  Y H Su; R L Meegalla; R Chowhan; C Cubitt; J E Oakes; R N Lausch; N W Fraser; T M Block
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  Transcriptional and translational analyses of the UL2 gene of equine herpesvirus 1: a homolog of UL55 of herpes simplex virus type 1 that is maintained in the genome of defective interfering particles.

Authors:  R N Harty; V R Holden; D J O'Callaghan
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.